Published on:

A federal class-action lawsuit on Elmiron was filed in October 2020. Its plaintiffs allege that it causes pigmentary maculopathy. This comes after recent studies have reported on Elmiron’s association with retinal damage.

These Elmiron eye damage lawsuits are expected to explode as people are learning that their eye injuries may be associated with Elmiron.  This could be an extremely large mass tort and it has earned the interest of drug injury lawyers everywhere.

Elmiron

Published on:

Beovu was supposed to be the big new revenue-making drug for pharmaceutical giant Novartis last year. Beovu was designed for the treatment of wet age-related macular degeneration (wet AMD), a common eye condition that can cause blindness if not treated. Novartis invested heavily in the development of Beovu and was counting on the drug’s dosing advantages to help it tap into the massive market share currently held by the leading AMD drug – Eylea. But an onslaught of major safety concerns and anticipated Beovu lawsuits quickly crushed the money-making potential of Beovu. Rather than abandon its investment, Novartis is now trying to repurpose Beovu to treat other eye conditions.

Development of Beovu

The treatment of certain common eye conditions, particularly age-related macular degeneration, is big business in the pharmaceutical world. Really big. Age-related macular degeneration (AMD) comes in 2 forms (wet and dry) and it is the leading cause of blindness in the world today. An estimated 11 million people in the U.S. suffer from AMD. If not properly managed and treated, AMD can result in serious vision impairment or blindness.

Published on:

According to the findings of a recent study, taking benzodiazepines such as Xanax or Valium during pregnancy could significantly raise a woman’s risk of having an ectopic pregnancy. In this study, published by Stanford University in the journal Human Reproduction, scholars found that pregnant women taking these drugs to reduce anxiety or induce sleep have a 50% increased chance of developing life-threatening complications.

Normal Pregnancies vs. Ectopic Pregnancies

In a normal pregnancy, a fertilized egg will attach itself to the lining of the uterus in order to begin the growing process. However, an ectopic pregnancy will occur if the fertilized egg implants and grows outside of the main cavity of the uterus.

Published on:

Breast augmentation is the most prevalent cosmetic procedure in the United States, with estimates ranging that 1 to 3 million women have some type of breast implant. For years, there has been developing research about the possibility of implants increase the risk of certain cancers, but the evidence was considered too slim to create any action towards addressing the problem.

breast implant cancerNow, the FDA has finally issued a safety warning about the risks of using breast implants manufactured by the company Allergan. The warning requested Allergan to recall all of their micro-textured implants in the United States, citing new sufficient evidence showing a link between their products and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). This recall will most likely cause a significant increase in breast implant cancer lawsuits, including class action lawsuits for medical monitoring.

The warning is not without precedent, as there have been similar recalls for Allergan breast implants in Canada, Australia, and France within the past year. However, the FDA was hesitant to issue on their own recall due to “insufficient evidence” that indicated a connection between textured implants and the rare lymphoma cancer. Despite this, hundreds of women around the country have been taking Allergan to court based on claims that their breast implants were the cause of their illness.

Published on:

A November 2018 article in the BMJ reported a study concluding what many lawyers have known for a long time: patients who use sodium-glucose cotransporter 2 (SGLT2) inhibitors are twice at risk of having lower limb amputations than other diabetes medications. The scientists also reported that SGLT2 inhibitors are also linked to diabetic ketoacidosis.

What Are SGLT2 Inhibitors?

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are medications that lower blood sugar in adults who have type 2 diabetes. They are used to complement diet and exercise. SGLT2 inhibitors may be available as a single-ingredient product or combined with other diabetic medications including metformin. They reduce the amount of glucose being absorbed by the body through the kidneys. This helps to reduce blood sugar by removing excess glucose through urine.

Published on:

A lawsuit recently filed in the U.S. District Court District of New Jersey alleges that someone received stomach cancer because of taking proton pump inhibitors (PPIs) Prilosec, Nexium, and the variations of both drugs.

PPIs are used to treat many stomach conditions but can create even worse problems in the stomach as well. Before informing yourself about these lawsuits, you must first inform yourself on PPIs, specifically Nexium and Prilosec. You must also inform yourself about their potential side effects.

What are proton pump inhibitors?

Proton pump inhibitors (PPIs) are medications that reduce the amount of stomach accident found in the stomach lining. They help relieve symptoms of acid reflux, a condition in which food or liquid goes back up to the esophagus. PPIs can also help treat stomach ulcers.

Also, they can treat lower esophagus damage resulting from acid reflux. PPIs can be used to treat heartburn as well. They come in various brand names such as Prilosec, Nexium, Prevacid, AcipHex, Protonix, Dexilant, or Zegerid.

What are PPI side effects?

Commonly found side effects may include a headache, diarrhea, constipation, nausea, and itching. Serious long-term side effects may include infections and bone fractures.

PPIs can also be very bad for your kidneys as well. According to an April 2016 study published in the Journal of the American Society of Nephrology, PPIs are linked to serious kidney complications. It showed that patients who took PPIs were about 96% more likely to get kidney failure than those who did not. PPIs users were also 28% more likely to develop chronic kidney disease after five years of taking PPIs.

According to a 2017 study published in Gut, there may be a link between PPIs and gastric cancer. This study was documented by Hong Kong-based researchers. They looked at 63,000 adults in Hong Kong over a nine-year span that ranged from 2003 to 2012.

They discovered that those who took PPIs such as Nexium and Prilosec doubled their risk of gastric cancer. This contrasts with other heartburn drugs, which did not increase any risk. The study is very relevant to the current lawsuit involving Nexium and Prilosec that is being filed in the New Jersey court.

Continue Reading

Published on:

On July 13, 2018, the Food and Drug Administration (FDA) recalled Valsartan because they contain the contaminant N-Nitrosodimethylamine (NDMA). The FDA noted that Valsartan products pose an unnecessary risk to patients.

Before we get to the 8 things you need to know, let’s get the latest Valsartan lawsuit update.

April 2022 Valsartan Lawsuit Update

Published on:

Researchers from Louisiana State University’s Health Science Center and Seattle Children’s Hospital were given a five-year federal grant by the National Institutes of Health (NIH) to study whether muscle power training exercises can improve the walking abilities of children with cerebral palsy (CP).

Is this exciting? It really is.  Anything that can advance the ball for people with cerebral palsy is wildly exciting.

How will this study be conducted?

Published on:

This page is about the Bair Hugger lawsuits that were filed claiming the product caused infections. But these suits did not go very far and I don’t know of any lawyers filing warning blanket lawsuits in 2021. Not all mass tort lawsuits work out and these Bair Hugger lawsuits certainly did not.

Let’s back up first to the start of this litigation.  I’m backfilling this first the original post…

As of September 2018, there are over 1,500 Bair Hugger warming blanket lawsuits pending in the MDL in Minnesota.

In one typical case, a New York couple claims that a surgical warming blanket used after the husband’s hip replacement operation caused severe infections, resulting in four additional surgeries. A man and his wife filed a lawsuit in New York on Nov. 25, 2015, against 3M, the manufacturer of the Bair Hugger forced-air warming system. Medical facilities commonly use this blanket during knee and hip replacement operations. In addition to 3M, the lawsuit lists Arizant Healthcare, Inc. and its subsidiaries as Defendants.

The value of surgical blanket lawsuits is still being determined

The value of surgical blanket lawsuits is still being determined, but many of these infection cases involve serious injury and death.

During the surgery on Oct. 24, 2012, medical personnel used a Bair Hugger on the man’s left hip, supposedly to help regulate body temperature. However, the warming blanket might have introduced bacteria into the surgical site, resulting in infection. Plaintiff received five surgeries within 16 months, including the original surgery, and he now struggles with mobility and needs crutches to walk.

Per the lawsuit: “Due to the infection, Plaintiff needed four additional surgical procedures to remove the implant and clean the infected area within sixteen months from the original implant surgery, and he continues to suffer limited mobility, requiring crutches to ambulate.”

According to diverse news reports, this Plaintiff is far from alone; many consumers across the nation have taken legal action after illnesses they’ve acquired after using the Bair Hugger, following hip and knee surgeries.

The Plaintiffs noted that 3M sent a letter to the FDA way back in June 1997, which warned of possible contamination issues with this product.

 

Continue Reading

Published on:

Sprue-like enteropathy is an intestinal condition involving chronic diarrhea, nausea, stomach severe stomach discomfort, and rapid weight loss.

Sprue-like enteropathy is very similar to celiac disease, which causes adverse reactions to the consumption of gluten.  Much like celiac disease, sprue-like enteropathy can damage and erode the intestinal villi (tiny finger-like fibers on the inside of the intestines that help absorbs nutrients from food).

This type of damage or erosion of the intestinal villi is referred to as villous atrophy.  When villous atrophy is caused by an adverse reaction to gluten, the condition is classified as celiac disease.